PRINCETON, NJ, Sept. 3 /CNW/ - NUCRYST Pharmaceuticals, a developer and
manufacturer of medical products that fight infection and the Advanced Wound
Management division of Smith & Nephew plc announced today the European launch
of Acticoat(TM) Flex3 and Acticoat(TM) Flex7. The Flex range is the newest
addition to the Acticoat(TM) portfolio of dressings with NUCRYST's proprietary
SILCRYST(TM) nanocrystalline silver coatings. Acticoat(TM) Flex is an
antimicrobial barrier dressing designed to conform to body contours and allow
for flexible movement for injuries that require sustained antimicrobial
activity.
"We are pleased to support Smith & Nephew in the European launch of
Acticoat(TM) Flex," said David B. Holtz, Interim President and Chief Executive
Officer, and Chief Financial Officer of NUCRYST. "The enhanced conformability
of Flex will now be available to European clinicians to simplifying the
dressing of wounds on difficult-to-protect articulating regions such as knee
or elbow joints while also providing advanced antimicrobial protection."
The CE Mark Certification for Acticoat(TM) Flex was received by Smith &
Nephew last week following the July 510(k) clearance in the United States and
market approval in Canada late last year.
"We are delighted that we can now offer our European clinicians this new
version of Acticoat(TM). The feedback on Acticoat(TM) Flex from the markets
where it recently became available has been excellent," commented Roger
Teasdale, President of Smith & Nephew Wound Management. "We are committed to
improving the quality of life of the patients treated with our products like
Acticoat(TM) Flex, which helps manage the risk of infection in patients with
serious wounds."
About Acticoat(TM) Dressings with SILCRYST(TM) Nanocrystals
Acticoat(TM) dressings with NUCRYST's proprietary SILCRYST(TM)
nanocrystalline silver coatings provide effective antimicrobial activity
thereby providing an improved environment for wound closure. Acticoat(TM)
dressings are now sold by Smith & Nephew in over 30 countries and are used
extensively for serious wounds and traumatic injury.
About Smith & Nephew
Smith & Nephew is a global medical technology business, specialising in
Orthopaedics, including Reconstruction, Trauma and Clinical Therapies,
Endoscopy and Advanced Wound Management products. Smith & Nephew is a global
leader in arthroscopy and advanced wound management and is one of the leading
global orthopaedics companies.
Smith & Nephew is dedicated to helping improve people's lives. The
Company prides itself on the strength of its relationships with its surgeons
and professional healthcare customers, with whom its name is synonymous with
high standards of performance, innovation and trust. The Company operates in
32 countries around the world.
